Mirae Asset Aggressive Hybrid Fund - Direct (G) vs UTI-Mid Cap Fund - Direct (G)

Mirae Asset Aggressive Hybrid Fund - Direct (G) vs UTI-Mid Cap Fund - Direct (G)

stock1

Mirae Asset Aggressive Hybrid Fund - Direct (G)

4.27%

stock2

UTI-Mid Cap Fund - Direct (G)

3.81%

Loading chart...

About Fund

-

-

Stock Holding Corporation of India Limited Citibank NA HDFC Bank Limited

Computer Age Management Services Pvt Ltd.(CAMS) Datamatics Financial Software & services Limited Karvy Computershare Pvt. Ltd. UTI Technology Services Ltd.

Very High Risk

5000

9426.19

-

39.055

July 8, 2015

0

Very High Risk

5000

12122.33

1.83

347.379

January 1, 2013

0

11.39 %

11.71 %

4.27 %

13.51 %

13.74 %

3.81 %

Harshad Borawake

MBA (Finance), B.E. (Polymers)

Mr. Borawake has professional experience of more than 12 years and his primary responsibility includes Investment Analysis & Research. Prior to this assignment, he was associated with Motilal Oswal Securities as Vice President (Research). He has also been associated with Capmetrics & Risk Solutions as Research Analyst - Equity.

Neelesh Surana

B.E. (Mechanical), MBA (Finance)

Mr. Neelesh Surana is Head of Equities at Mirae Asset Global Investments (India) Pvt. Ltd. He joined Mirae Asset in 2008. In his capacity as Head of Equities, Neelesh spearheads the equity research and investment function. He is responsible for the managing existing equity funds of Mirae Asset (India), as well as, providing research support for the global mandate. Following others Schemes of the Fund are managed or co-managed by him: i. Mirae Asset India Opportunities Fund (to be renamed to 'Mirae Asset India Equity Fund' with effect from March 01, 2018), ii. Mirae Asset Prudence Fund (to be renamed as 'Mirae Asset Hybrid-Equity Fund' with effect from March 14, 2018) iii. Mirae Asset Tax Saver Fund iv. Mirae Asset Great Consumer Fund An engineering graduate with MBA in Finance, Neelesh has over 18 years of experience in equity research and portfolio management. Prior to Mirae, Neelesh was with ASK Investment Managers Ltd., as Senior Portfolio Manager responsible for managing domestic and international portfolios. a

Sudhir Kedia

CA, CMA, MBA (PGPEBiz)

Mr. Kedia has professional experience of more than 13 years and his primary responsibility includes Fund Management & Investment Analysis. He was previously associated with ASK Investments.

Ankit Agarwal

PGDM, Indian Institute of Management (IIM) Bangalore, B. Tech National Institute of Technology, Trichy

Ankit Agarwal joined UTI in August 2019. Presently he has been designated as Fund Manager; managing Mr. Ankit Agarwal has an impressive career with over 20 years of investment experience across asset management, portfolio management, equity research, and capital markets. Mr. Agarwal was engaged with UTI AMC, where he gained extensive experience in equity research across healthcare, telecom, technology and midcap sectors. He also contributed to Barclays Wealth, providing investment research and insights tailored for high-net-worth clients. Mr. Agarwal's professional journey includes global exposure through roles at Lehman Brothers (London), BNP Paribas (Hong Kong) and D. E. Shaw (Proprietary trading systems).

Anoop Bhaskar

B.Com., MBA (Finance).

Prior to joining IDFC AMC, he was associated with UTI AMC (Apr 2007-Jan 2016), Sundaram AMC (Aug 2003-Mar 2007), Franklin Templeton AMC, Shriram Financial Services Ltd, Brisk Financial Services and Cross Borders Finance & Projects.

Lalit Nambiar

B.Com.,MMS and CFA., B.Com., MMS, CFA

Prior to joining UTI AMC (Since Aug -2008),he was with SBI Capital Markets Ltd.as AVP in Research Dept., as Research Analyst with UTI Sec Ltd. and with IIT Investrust Ltd. as Sr.Manager in Research Dept.

Vishal Chopda

BE, PGDM, CFS

He has completed his BE from Mumbai University. He is a CFA Charter holder from The CFA Institute, USA and also holds a PGDM from MDI, Gurgaon. He joined UTI AMC in January 2011 and worked for the past 7 years as Research Analyst. He has previously worked with CARE Ratings (Credit Analysis and Research Ltd).

Get your FAQs right